Fundraising Fox

Clade Therapeutics

Cambridge, US · Founded 2020 · Delaware corporation · 7 employees on LinkedIn · 9 known investors

Biotech

Founders & leadership

Clade Therapeutics was founded in 2020 by Chad A. Cowan.

CA
Chad A. CowanFounder
LV
Leandro VetcherNamed on SEC filing
DV
Daniel VasellaNamed on SEC filing
JG
Jim GlasheenNamed on SEC filing
NW
Neil WhiteNamed on SEC filing

Board

MM
Martin MurphyBoard director

Investors · 9

SynconaLondon
Bain Capital Life SciencesreportedBoston
Casdin CapitalreportedNew York
Venrock Healthcare Capital PartnersreportedNew York

Also in the syndicate · 5

Adage Capital Partners LPleadBoxer CapitalDAFNA Capital ManagementOctagon CapitalleadSuperstring Capitallead

Funding

SEC filings, press & company announcements

$45.9M disclosed across 2 of 3 rounds · 2021–2024

▶$42KraisedJan 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Chad A. CowanExecutive Officer, Director
  • Martin MurphyDirector
  • Daniel VasellaDirector
  • Jim GlasheenExecutive Officer, Director
  • Neil WhiteDirector
  • Leandro VetcherExecutive Officer
Offering amount
$66K
Amount sold
$42K
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45.9MraisedNov 2021 · 31 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Leandro VetcherExecutive Officer
  • Daniel VasellaDirector
  • Jim GlasheenExecutive Officer, Director
  • Neil WhiteDirector
  • Chad A. CowanExecutive Officer, Director
  • Martin MurphyDirector
Offering amount
$87.1M
Amount sold
$45.9M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Century buys a startup, raises funding in cell therapy expansion | BioPharma Divebiopharmadive.com · Apr 2024Cambridge Massachusetts based Clade Therapeutics is raising $87,142,085.00 in New Equity Investment. - intelligence360intelligence360.news · Dec 2021Clade Therapeutics clasps $87m - Global Venturingglobalventuring.com · Nov 2021Clade and GRObio Land Series A Funds for Cancer, Protein Therapeutics - BioSpacebiospace.com · Nov 2021Clade Therapeutics Launches With $87 Million Series A | Inside Precision Medicineinsideprecisionmedicine.com · Nov 2021Clade Therapeutics Raises $87 Million Series A Financing to Realize the Potential of Cell Therapyglobenewswire.com · Nov 2021

Frequently asked questions

Who founded Clade Therapeutics?
Clade Therapeutics was founded by Chad A. Cowan in 2020.
Who are Clade Therapeutics's investors?
Clade Therapeutics's investors include Syncona, Bain Capital Life Sciences, Casdin Capital, Venrock Healthcare Capital Partners.
How much funding has Clade Therapeutics raised?
Clade Therapeutics has disclosed $45.9M raised across 2 of its 3 known rounds.
Where is Clade Therapeutics headquartered?
Clade Therapeutics is headquartered in Cambridge, US.